Dr. Martin C Faulkes
Dr. Martin C Faulkes Executive Chairman

Dr. Martin Faulkes has over 30 years of entrepreneurial and managerial experience as the founder and CEO of several software companies within the United Kingdom and the United States.

From 1979 to 1984, Dr. Faulkes was the Founder, President and CEO for Logica Inc., a company providing be...

Watch video
Cameron Reynolds
Cameron Reynolds President & Group Chief Executive Officer

Cameron is the President and Group Chief Executive Officer of Volition and was one of the founders of the company in 2010. He is an experienced entrepreneurial executive, with expertise in a wide range of fields, including several biotechnology companies and has led Volition through the research ...

Watch video
Dr. Alan Colman
Dr. Alan Colman Non-Executive Director

Alan Colman obtained a BA degree in Biochemistry in Oxford (1971) and a PhD under John Gurdon, a pioneer of the field of nuclear transfer, at the Laboratory of Molecular Biology in Cambridge, UK (1974). After a series of academic appointments in Oxford and Warwick Universities, he became Professo...

Read more
Guy Innes
Guy Innes Non-Executive Director

Guy Archibald Innes is a Chartered Accountant and a member of the Institute of Chartered Accountants in England and Wales.

Mr. Innes has extensive experience in financing and managing technology companies, which he gained from serving as a non-executive director on the board of companies s...

Read more
Dr. Edward Futcher
Dr. Edward Futcher Non-Executive Director

Dr. Futcher holds a B.Sc. in Physics and a Ph.D. in Physics from the University of London and has extensive experience in engineering and management in high technology companies.  Since 1997, Dr. Futcher has held non-executive directorships at a variety of private companies. He co-founded Azima, ...

Read more
Dr. Martin C Faulkes
Dr. Martin C Faulkes Executive Chairman

Dr. Martin Faulkes has over 30 years of entrepreneurial and managerial experience as the founder and CEO of several software companies within the United Kingdom and the United States.

From 1979 to 1984, Dr. Faulkes was the Founder, President and CEO for Logica Inc., a company providing bes...

Watch video
Cameron Reynolds
Cameron Reynolds President & Chief Executive Officer

Cameron is an experienced entrepreneurial executive, with expertise in biotechnology companies. He has extensive experience in the management, structuring, and strategic planning of start-up companies and has held positions including Chief Executive Officer, Chief Financial Officer, and Non-Execu...

Watch video
Terig Hughes
Terig Hughes Group Chief Financial Officer

Terig is the Group Chief Financial Officer of Volition having joined the company in February 2021. He is a seasoned finance professional with over twenty-five years of accounting, finance and business management experience, including product commercialization, licensing and distributor management...

Watch video
Gaetan Michel
Gaetan Michel Chief Operating Officer

Gaetan is the Chief Operating Officer and has been a valued member of the Volition team since 2014 serving firstly as Chief Operating Officer of Belgian Volition and latterly as Chief Executive Officer of Belgian Volition. With over 15 years’ project management, manufacturing and operational expe...

Watch video
Gael Forterre
Gael Forterre Chief Commercial Officer

Gael is the Chief Commercial Officer of Volition joining the team in 2021. He is focused on building a strong commercialization plan and team to drive the extensive range of products developed using the Nu.Q™ platform.

Gael has extensive experience investing in and scaling fast growing com...

Watch video
Jake Micallef
Jake Micallef Chief Scientific Officer

Jake is the Chief Scientific Officer and one of the founding scientists of Volition. He is an experienced scientist with expertise in research and development and in the management of early-stage biotechnical companies, including the manufacturing of biotechnology products and the establishment o...

Watch video
Louise Batchelor
Louise Batchelor Chief Marketing & Communications Officer

Louise is the Chief Marketing and Communications Officer of Volition and has been a valued member of the team since joining in 2016. She brings more than 25 years of marketing, sales and leadership experience to her role at Volition. Formerly Louise worked in various roles at Reckitt Benckiser in...

Watch video
Jasmine Kway
Jasmine Kway Chief Executive Officer, Singapore Volition

Jasmine is the Chief Executive Officer of Singapore Volition having joined the company in 2017. She has a proven track record of developing strategic business alliances and has established great connections across Asia for Volition. As a thought leader in technology management and commercializati...

Watch video
Jason Terrell
Jason Terrell Chief Medical Officer & Chief Executive Officer of Volition America, Inc.

Jason Is Volition’s Chief Medical Officer and also serves as the Chief Executive Officer of Volition America Inc. He has a strong grounding in both medicine and more specifically in diagnostics and product commercialization and has led both the clinical trial development program in the U.S. for V...

Watch video
Dr Tom Butera
Dr Tom Butera Chief Executive Officer, Volition Veterinary Diagnostics Development LLC

Tom Butera is a Doctor of Veterinary Medicine with more than 40 years of experience in equine and small animal health in private practice as well as extensive work in both business development and management of veterinary companies. Since 2016, he has been actively involved in business developmen...

Watch video
Heather Wilson-Robles
Heather Wilson-Robles Chief Medical Officer, Volition Veterinary Diagnostics Development LLC

Heather is a well-established veterinary medical oncologist specializing in canine models of human cancer. Her research over the past 12 years has focused on improving canine models of pediatric and adult cancers and translating these findings to the mutual benefit of both species. Her basic rese...

Read more
Mark Eccleston
Mark Eccleston Chief Technology Officer

Mark is the Chief Technology Officer and one of the founding scientists of Volition. He is an enthusiastic and passionate biotechnology entrepreneur with over 25 years’ experience in the sector. He is focused not only on identifying new and innovative technology platforms, but also on ensuring th...

Watch video
Rod Rootsaert
Rod Rootsaert Corporate Secretary

Rod is our Corporate Secretary and has been part of the Volition team right from its beginnings in 2011. He is an experienced legal and corporate secretary with over fifteen years’ experience in providing corporate, legal and administrative services to start-up companies. He previously served as ...

Watch video
Scott Powell
Scott Powell Executive Vice President, Investor Relations & Chief Financial Officer of Volition America, Inc.

Scott is our Executive Vice President of Investor Relations and also serves as the Chief Financial Officer for Volition America Inc. He communicates regularly with existing and potential investors both one to one and at set piece conferences. Scott has over 20 years of experience in the U.S. capi...

Watch video
Terry Kelly
Terry Kelly Chief Scientific Officer, Volition America Inc

Terry has over 10 years of experience in Epigenetics including developing novel technologies and seeing them through to commercialization. She previously was the R&D Director at Active Motif and the Global leader for custom assays and services and Agena Bioscience. She received her PhD from U...

Read more
Marielle Herzog
Marielle Herzog Research & Development Director

Marielle is an epigeneticist with nearly 15 years research experience at the Institute of Genetics and Molecular and Cellular Biology (IGBMC), Strasbourg, the Laboratory ofCancer Epigenetics, Free University of Brussels and as the R&D director at Volition. She manages a team of four project m...

Read more
Dr. Alan Colman
Dr. Alan Colman

Alan Colman obtained a BA degree in Biochemistry in Oxford (1971) and a PhD under John Gurdon, a pioneer of the field of nuclear transfer, at the Laboratory of Molecular Biology in Cambridge, UK (1974). After a series of academic appointments in Oxford and Warwick Universities, he became Professo...

Read more
Dr. Jorge Reis-Filho
Dr. Jorge Reis-Filho

Dr. Jorge Reis-Filho is the Director of Experimental Pathology at Memorial Sloan Kettering Cancer Center in New York. His research focuses on massively parallel sequencing analysis of rare types of breast cancers for the development of a predictive molecular classification of the disease and on t...

Read more
Prof. Axel Imhof
Prof. Axel Imhof Ludwig-Maximilians University of Munich

Dr. Axel Imhof is a professor for protein analytics at the Biomedical Center of the Ludwig-Maximilians University of Munich (LMU) and the director of the Proteomics Core Facility of LMUs Biomedical Center. His lab is among the world leading groups for the characterization of chromatin bound prote...

Read more
Dr. Adrian Schomburg
Dr. Adrian Schomburg

Dr. Adrian Schomburg is the CEO and co-founder of Eisbach Bio, a Munich based oncology drug discovery company built on strong nucleosome based assays and disease biology. Adrian is also the founder of Octamer – which focuses on the development and production of high-quality nucleosomes for indust...

Read more
Prof. Stefan Holdenrieder
Prof. Stefan Holdenrieder

Prof Stefan Holdenrieder is Director of the Institute of Laboratory Medicine at the German Heart Center of the Technical University Munich. Germany. Being a specialist in laboratory medicine his research interests are the development and comprehensive validation of new biomarkers and technologies...

Read more
Dr. Robert Weinzierl
Dr. Robert Weinzierl

Dr. Robert Weinzierl is a Reader in Molecular Biology at Imperial College London, and is the inventor of the HyperGenomics® technology, which Volition is now developing further.

Prior to joining Imperial, he carried out doctoral work at the University of Cambridge (Akam/White laboratories)...

Read more
Prof. Andreas Ladurner
Prof. Andreas Ladurner

Professor Andreas Ladurner has been Chair of Physiological Chemistry in the Faculty of Medicine of the Ludwig-Maximilians-University of Munich (LMU) since 2010. His team’s research focuses on the molecular mechanisms of chromatin plasticity and gene-environment interactions.

Prior to joini...

Read more
Dr. Lee-Jen Wei
Dr. Lee-Jen Wei

Dr. Lee-Jen Wei is a professor of Biostatistics at Harvard University and has a wealth of experience. His main area of research is developing statistical methods for the design and analysis of clinical trials. He was named as a Cancer Expert by The National Cancer Institute and is a multi-award-w...

Read more
Dr. Roland Andersson
Dr. Roland Andersson

Dr. Roland Andersson is Professor of Surgery and Vice-Dean of the Medical Faculty, Lund University, Sweden; and President of the Scandinavian Hepato-Pancreatico-Biliary Chapter. Dr Andersson is a highly-experienced liver, biliary and pancreatic surgeon and oncologist who has authored more than 40...

Read more
The Research Team

The research team based in Namur bring together years of scientific experience with the passion that is commonplace at Volition. Using their extensive knowledge, the team is dedicated to developing diagnostic tools that will relieve the burden of cancer worldwide; for the patient...

Read more
Dr. Phillip Barnes Non-Executive Director

Dr. Barnes is a British physician with extensive experience both as a clinician and clinical manager within the UK National Health Service and related academic institutions. He was Consultant Neurologist at King’s College Hospital London from 1995-2009 and Hon Senior Lecturer in Neurology at King...

Read more
Ms Kim Nguyen
Ms Kim Nguyen Independent Director

Ms. Nguyen is an international HR professional with over 20 years-experience working with fast growing multinational technology companies covering Europe, Middle East & Africa, Latin America and Asia Pacific (“APAC”) markets. Ms. Nguyen currently serves as Head of HR for Google Asia Pacific P...

Read more
Mr Richard Brudnick
Mr Richard Brudnick Independent Director

Mr. Brudnick has held senior positions in the areas of Portfolio Strategy & Business Development and Corporate Development in a number of pharmaceutical companies and currently serves as Chief Business Officer and Head of Corporate Strategy of Codiak BioSciences, Inc., (NASDAQ GS: CDAK), a cl...

Read more
arrow-downarrow-leftarrow-rightarrowchevron-downcircle-link--redcircle-linkcloseplayplus